CCL3 has been reported to be upregulated in various types of cancers, including chondrosarcoma, non-small cell lung cancer, and oral squamous cell carcinoma, and functions as an oncogene [28, 35–37]. The gene discussed is CCL3; the disease is non-small cell lung carcinoma.